Medicare
AHA shares the hospital field’s comments on legislative proposals for consideration before the Energy and Commerce Committee Health Subcommittee on Oct. 19.
AHA on Oct. 19 submitted a statement to the House Energy and Commerce Health Subcommittee on legislative proposals involving Medicare.
The Medicare Part A deductible for inpatient hospital services will increase by $32 in calendar year 2024, to $1,632, the Centers for Medicare & Medicaid Services announced Oct. 12.
AHA Urges CMS to Rigorously Enforce New Policies to Safeguard MA Coverage
The companies that make the first 10 Medicare Part D drugs selected to participate in the Medicare Drug Price Negotiation Program have agreed to participate in the program’s price negotiations, the Centers for Medicare & Medicaid Services announced.
As millions of people are losing their Medicaid coverage as a result of the redetermination process, hospitals and health systems are seeing substantial increases in uncompensated care and facing new Medicare cuts that will exacerbate their financial challenges, according to a AHA blog post …
This October through December under the Inflation Reduction Act, Medicare will reduce the beneficiary coinsurance amount for 34 Part B prescription drugs between $1 and $618 per average dose, the Centers for Medicare & Medicaid Services announced recently.
The Department of Health and Human Services announced the first list of Medicare Part D drugs subject to price negotiations, a tenet of the Inflation Reduction Act designed to reduce health care costs.
The Centers for Medicare & Medicaid Services Aug. 25 reported that the Medicare Shared Savings Program saved the agency $1.8 billion in 2022. This marks the sixth consecutive year of cost savings for the program, and the second highest savings year reported since the program started.
As some members of Congress propose to weaken Medicare’s prohibition on physician self-referral to new physician-owned hospitals and ease restrictions on their growth, new data from Dobson | DaVanzo show that POHs publicly report on fewer Medicare quality measures and perform worse on readmission…